A randomized, double-blind, Phase 3 study comparing efficacy and safety of frexalimab (SAR441344) to placebo in adult participants with nonrelapsing secondary progressive multiple sclerosis

Is this Study for You?

Let's Get Started!




Brain Imaging Center - BIC
Department Specific Free Standing Clinic
Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Enrique Alvarez

Enrique Alvarez

Study ID

Protocol Number: 23-2271

More information available at ClinicalTrials.gov: NCT06141486

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers